Section
Health
7 articles
Advertisement
AdSense slot • banner
Largest Opioid Review Finds Limited Efficacy for Acute Pain
The most extensive review ever conducted on opioids for acute pain has concluded that these widely prescribed medications often provide only small, short-lived benefits. For numerous common conditions, including some surgical procedures and kidney stone pain, the review found that opioids were no more effective than a placebo. Researchers also identified higher rates of side effects and issued a warning regarding the potential for dependence to develop after only a brief period of use.
NHS Doctors Face Potential Lawsuits Over AI Medical Errors, Report Warns
Doctors and the National Health Service (NHS) in the UK could be held liable for medical negligence resulting from mistakes made by artificial intelligence (AI) tools. A report warns ministers that current law allows for medics and the health service to be sued for patient harm or death, even when AI errors are the cause. The Medical Protection Society is advocating for an overhaul of the existing legislation to shield medical professionals from such liability.
FDA Approves First New Sunscreen Ingredient in Years
The U.S. Food and Drug Administration (FDA) has reportedly approved a new sunscreen ingredient, marking the first such regulatory clearance for an active component in several years. This decision is considered a significant development for the sunscreen market, potentially leading to new formulations and expanded options for consumers seeking protection from ultraviolet radiation. Details regarding the specific ingredient or its market availability were not immediately available.
David Sinclair Plans Human Trials for Whole-Body Rejuvenation Drug in XPrize Competition
Longevity scientist David Sinclair, a biologist at Harvard Medical School, intends to launch human trials for an oral "reprogramming" drug. This initiative is part of a $101 million competition organized by the XPrize Foundation, which aims to reward teams capable of achieving a significant age restoration in individuals. The competition seeks a 10-year or greater improvement in a person's apparent age, measured by immune, cognitive, and muscle function, after one year of treatment. Sinclair's team will administer an oral drug mixture to volunteers, aiming to demonstrate evidence of age restoration in humans through epigenetic reprogramming.
Longevity Startup Initiates First Human Trial for Age-Related Sight Loss
A longevity startup has administered its ER-100 cellular rejuvenation therapy to its first human participant. This development follows recent approval from the FDA for human clinical trials. The primary goal of the trial is to address and potentially reverse age-related sight loss, with broader applications for various age-related diseases also being considered.
USDA Reports Multiple Screwworm Cases in US
The U.S. Department of Agriculture (USDA) has confirmed a total of five screwworm cases in the United States, including three newly reported infections. Four cases involve calves in Texas, specifically in Zavala and La Salle counties. An additional case was found in a dog residing in New Mexico, which was reported in Texas and may have recently traveled to Mexico. The reemergence of these flesh-eating flies raises concerns primarily for the livestock industry due to potential significant financial losses.
Research Examines Connection Between Ultra-Processed Foods and Tobacco Industry
New research published in the American Journal of Public Health highlights connections between ultra-processed foods and the tobacco industry. The study details similarities in production, strategy, and marketing approaches observed across both sectors. This research provides insight into the methods employed by industries in the context of public health.